Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma
Dr Larkin talks to ecancertv at ASCO 2015 about an update on a phase III study of cobimetinib plus vemurafenib in advanc... Read more
8 Aug 2017
•
3mins
ASCO 2015: Latest developments in multiple myeloma
ASCO 2015: Latest developments in multiple myeloma
Prof Moreau (Centre Hospitalier Universitaire de Nantes, Nantes, France) chairs a discussion for ecancertv with Prof Lon... Read more
8 Aug 2017
•
10mins
Medically under-represented populations: Refining the calculation of accrual targets
Medically under-represented populations: Refining the calculation of accrual targets
Dr Comis talks to ecancertv at ASCO 2015 about a National Cancer Institute (NCI) sponsored cancer clinical trial for und... Read more
8 Aug 2017
•
4mins
Initial nivolumab-based treatment halts melanoma progression
Initial nivolumab-based treatment halts melanoma progression
Dr Wolchok talks to ecancertv at ASCO 2015 about results from a randomised phase III trial which indicate that initial t... Read more
8 Aug 2017
•
6mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma
Dr Larkin talks to ecancertv at ASCO 2015 about the results of a randomised phase II trial of kinase inhibitor lenvatini... Read more
8 Aug 2017
•
4mins
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Dr Francesco talks to ecancertv at ASCO 2015 about the data from a study of 720 patient metastatic melanoma patients usi... Read more
8 Aug 2017
•
5mins
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer
Dr Harrington talks to ecancertv at ASCO 2015 about a phase III randomised trial of pembrolizumab (MK-3475) versus stand... Read more
8 Aug 2017
•
5mins
Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma
Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma
Prof Wu talks to ecancertv at ASCO 2015 about EGFR inhibition in lung cancer.
8 Aug 2017
•
4mins
Advanced DNA sequencing test used to match rare cancers
Advanced DNA sequencing test used to match rare cancers
Dr Doroshow (National Cancer Institute, Bethesda, USA), Dr Flaherty (Massachusetts General Hospital, Boston, USA) and Dr... Read more
8 Aug 2017
•
16mins
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Dr Chowdhury talks to ecancertv at ASCO 2015 about the results of the TERRAIN study which looked at the use of 160 mg of... Read more
8 Aug 2017
•
7mins
